{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:55:45Z","timestamp":1794945345485,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"crossref","award":["330441.01.01.2016488.10"],"award-info":[{"award-number":["330441.01.01.2016488.10"]}],"id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0772-z","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T14:22:10Z","timestamp":1518013330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-208X","authenticated-orcid":false,"given":"Ashley","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Theos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Redden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Korf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"issue":"Pt 6","key":"772_CR1","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988;111(Pt 6):1355\u201381.","journal-title":"Brain"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R","volume":"66","author":"L Dugoff","year":"1996","unstructured":"Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet. 1996;66:7\u201310.","journal-title":"Am J Med Genet"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000327379","volume":"222","author":"TA Duong","year":"2011","unstructured":"Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P. Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients. Dermatology. 2011;222:269\u201373.","journal-title":"Dermatology"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","volume":"137","author":"P Wolkenstein","year":"2001","unstructured":"Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol. 2001;137:1421\u20135.","journal-title":"Arch Dermatol"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000187594","volume":"218","author":"Y Kodra","year":"2009","unstructured":"Kodra Y, Giustini S, Divona L, Porciello R, Calvieri S, Wolkenstein P, et al. Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology. 2009;218:215\u201320.","journal-title":"Dermatology"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","volume":"140","author":"PZ Page","year":"2006","unstructured":"Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P. Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. Am J Med Genet A. 2006;140:1893\u20138.","journal-title":"Am J Med Genet A"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00000637-199106000-00016","volume":"26","author":"DW Becker Jr","year":"1991","unstructured":"Becker DW Jr. Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas. Ann Plast Surg. 1991;26:582\u20136.","journal-title":"Ann Plast Surg"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00000637-198204000-00002","volume":"8","author":"GS Bromley","year":"1982","unstructured":"Bromley GS, Sherman JE, Goulian D Jr. Neurofibromatosis-distribution of lesions and surgical treatment. Ann Plast Surg. 1982;8:272\u20136.","journal-title":"Ann Plast Surg"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10103-007-0485-3","volume":"23","author":"TF Elwakil","year":"2008","unstructured":"Elwakil TF, Samy NA, Elbasiouny MS. Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulation. Lasers Med Sci. 2008;23:301\u20136.","journal-title":"Lasers Med Sci"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1524-4725.2012.02357.x","volume":"38","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Lee KG, Yi SM, Kim JH, Kim IH. Successful treatment of multiple cutaneous neurofibromas using a combination of shave excision and laser photothermocoagulation with a 1,444-nm neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2012;38:960\u20133.","journal-title":"Dermatol Surg"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"602e","DOI":"10.1097\/PRS.0b013e3182419d22","volume":"129","author":"LK Kriechbaumer","year":"2012","unstructured":"Kriechbaumer LK, Susani M, Kircher SG, Happak W. Vaporization of cutaneous neurofibromas with an erbium: yttrium-aluminum-garnet laser: a comparative histologic evaluation. Plast Reconstr Surg. 2012;129:602e\u20134e.","journal-title":"Plast Reconstr Surg"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000368078","volume":"230","author":"C Meni","year":"2015","unstructured":"Meni C, Sbidian E, Moreno JC, Lafaye S, Buffard V, Goldzal S, et al. Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patients. Dermatology. 2015;230:263\u20138.","journal-title":"Dermatology"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1046\/j.1365-2133.2001.04214.x","volume":"144","author":"JC Moreno","year":"2001","unstructured":"Moreno JC, Mathoret C, Lantieri L, Zeller J, Revuz J, Wolkenstein P. Carbon dioxide laser for removal of multiple cutaneous neurofibromas. Br J Dermatol. 2001;144:1096\u20138.","journal-title":"Br J Dermatol"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1524-4725.1987.tb00517.x","volume":"13","author":"RK Roenigk","year":"1987","unstructured":"Roenigk RK, Ratz JL. CO2 laser treatment of cutaneous neurofibromas. J Dermatol Surg Oncol. 1987;13:187\u201390.","journal-title":"J Dermatol Surg Oncol"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13023-014-0202-9","volume":"9","author":"KS Cunha","year":"2014","unstructured":"Cunha KS, Rozza-de-Menezes RE, Andrade RM, Theos A, Luiz RR, Korf B, et al. Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames. Orphanet J Rare Dis. 2014;9:202.","journal-title":"Orphanet J Rare Dis"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12350-015-0175-7","volume":"23","author":"CJ Morgan","year":"2016","unstructured":"Morgan CJ, Aban I. Methods for evaluating the agreement between diagnostic tests. J Nucl Cardiol. 2016;23:511\u20133.","journal-title":"J Nucl Cardiol"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10048-010-0240-y","volume":"11","author":"L Thomas","year":"2010","unstructured":"Thomas L, Kluwe L, Chuzhanova N, Mautner V, Upadhyaya M. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. Neurogenetics. 2010;11:391\u2013400.","journal-title":"Neurogenetics"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.20776","volume":"56","author":"SL Carroll","year":"2008","unstructured":"Carroll SL, Ratner N. How does the Schwann cell lineage form tumors in NF1? Glia. 2008;56:1590\u2013605.","journal-title":"Glia"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","volume":"5","author":"S Laycock-van Spyk","year":"2011","unstructured":"Laycock-van Spyk S, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics. 2011;5:623\u201390.","journal-title":"Hum Genomics"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, et al. Activity of Selumetinib in Neurofibromatosis type 1-related Plexiform Neurofibromas. N Engl J Med. 2016;375:2550\u201360.","journal-title":"N Engl J Med"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1517\/13543784.2013.772979","volume":"22","author":"DH Gutmann","year":"2013","unstructured":"Gutmann DH, Blakeley JO, Korf BR, Packer RJ. Optimizing biologically targeted clinical trials for neurofibromatosis. Expert Opin Investig Drugs. 2013;22:443\u201362.","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0772-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:07:49Z","timestamp":1589846869000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0772-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0772-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of Alabama at Birmingham\u2019s Institutional Review Board. All study participants provided written, informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants provided written, informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"31"}}